MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaiser, S.
Right arrow Articles by Wonnacott, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaiser, S.
Right arrow Articles by Wonnacott, S.

Vol. 58, Issue 2, 312-318, August 2000

alpha -Bungarotoxin-Sensitive Nicotinic Receptors Indirectly Modulate [3H]Dopamine Release in Rat Striatal Slices via Glutamate Release

Sergio Kaiser1 and Susan Wonnacott

Department of Biology and Biochemistry, University of Bath, Bath, United Kingdom

Nicotinic agonists elicit the release of dopamine from striatal synaptosomes by acting on presynaptic nicotinic acetylcholine receptors (nAChRs) on dopamine nerve terminals. Both alpha 3beta 2* and alpha 4beta 2 nAChR subtypes (but not alpha 7* nAChRs) have been implicated. Here, we compared nAChR-evoked [3H]dopamine release from rat striatal synaptosome and slice preparations by using the nicotinic agonist anatoxin-a. In the more integral slice preparation, the concentration-response curve for anatoxin-a-evoked [3H]dopamine release was best fitted to a two-site model, giving EC50 values of 241 nM and 5.1 µM, whereas only the higher-affinity component was observed in synaptosome preparations (EC50 = 134 nM). Responses to a high concentration of anatoxin-a (25 µM) in slices (but not in synaptosomes) were partially blocked by ionotropic glutamate receptor antagonists (kynurenic acid, 6,7-dinitroquinoxaline-2,3-dione) and by alpha 7*-selective nAChR antagonists (alpha -bungarotoxin, alpha -conotoxin-ImI, methyllycaconitine) in a nonadditive manner. In contrast, the alpha 3beta 2-selective nAChR antagonist alpha -conotoxin-MII partially inhibited [3H]dopamine release from both slice and synaptosome preparations, stimulated with both low (1 µM) and high (25 µM) concentrations of anatoxin-a. Antagonism by alpha -conotoxin-MII was additive with that of alpha 7*-selective antagonists. These data support a model in which alpha 7* nAChRs on striatal glutamate terminals elicit glutamate release, which in turn acts at ionotropic glutamate receptors on dopamine terminals to stimulate dopamine release. In addition, non-alpha 7* nAChRs on dopamine terminals also stimulate dopamine release. These observations have implications for the complex cholinergic modulation of inputs onto the major efferent neurons of the striatum.


1 Present address: Department of Biology, University of California, San Diego, 9500 Gilman Dr., La Jolla, CA 92093-0357.


Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
N. Innocent, P. D. Livingstone, A. Hone, A. Kimura, T. Young, P. Whiteaker, J. M. McIntosh, and S. Wonnacott
{alpha}Conotoxin Arenatus IB[V11l,V16D] Is a Potent and Selective Antagonist at Rat and Human Native {alpha}7 Nicotinic Acetylcholine Receptors
J. Pharmacol. Exp. Ther., November 1, 2008; 327(2): 529 - 537.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. P. Dwoskin, T. E. Wooters, S. P. Sumithran, K. B. Siripurapu, B. M. Joyce, P. R. Lockman, V. K. Manda, J. T. Ayers, Z. Zhang, A. G. Deaciuc, et al.
N,N'-Alkane-diyl-bis-3-picoliniums as Nicotinic Receptor Antagonists: Inhibition of Nicotine-Evoked Dopamine Release and Hyperactivity
J. Pharmacol. Exp. Ther., August 1, 2008; 326(2): 563 - 576.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
Z. Liu, Y. Otsu, C. Vasuta, H. Nawa, and T. H. Murphy
Action-Potential-Independent GABAergic Tone Mediated by Nicotinic Stimulation of Immature Striatal Miniature Synaptic Transmission
J Neurophysiol, August 1, 2007; 98(2): 581 - 593.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Solinas, M. Scherma, L. Fattore, J. Stroik, C. Wertheim, G. Tanda, W. Fratta, and S. R. Goldberg
Nicotinic {alpha}7 Receptors as a New Target for Treatment of Cannabis Abuse
J. Neurosci., May 23, 2007; 27(21): 5615 - 5620.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Barik and S. Wonnacott
Indirect Modulation by {alpha}7 Nicotinic Acetylcholine Receptors of Noradrenaline Release in Rat Hippocampal Slices: Interaction with Glutamate and GABA Systems and Effect of Nicotine Withdrawal
Mol. Pharmacol., February 1, 2006; 69(2): 618 - 628.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. van Nierop, S. Bertrand, D. W. Munno, Y. Gouwenberg, J. van Minnen, J. D. Spafford, N. I. Syed, D. Bertrand, and A. B. Smit
Identification and Functional Expression of a Family of Nicotinic Acetylcholine Receptor Subunits in the Central Nervous System of the Mollusc Lymnaea stagnalis
J. Biol. Chem., January 20, 2006; 281(3): 1680 - 1691.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Hamada, J. P. Hendrick, G. R. Ryan, M. Kuroiwa, H. Higashi, M. Tanaka, A. C. Nairn, P. Greengard, and A. Nishi
Nicotine Regulates DARPP-32 (Dopamine- and cAMP-Regulated Phosphoprotein of 32 kDa) Phosphorylation at Multiple Sites in Neostriatal Neurons
J. Pharmacol. Exp. Ther., November 1, 2005; 315(2): 872 - 878.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. Escubedo, C. Chipana, M. Perez-Sanchez, J. Camarasa, and D. Pubill
Methyllycaconitine Prevents Methamphetamine-Induced Effects in Mouse Striatum: Involvement of {alpha}7 Nicotinic Receptors
J. Pharmacol. Exp. Ther., November 1, 2005; 315(2): 658 - 667.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Quik, S. Vailati, T. Bordia, J. M. Kulak, H. Fan, J. M. McIntosh, F. Clementi, and C. Gotti
Subunit Composition of Nicotinic Receptors in Monkey Striatum: Effect of Treatments with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine or L-DOPA
Mol. Pharmacol., January 1, 2005; 67(1): 32 - 41.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. L. Parker, Y. Fu, K. McAllen, J. Luo, J. M. McIntosh, J. M. Lindstrom, and B. M. Sharp
Up-Regulation of Brain Nicotinic Acetylcholine Receptors in the Rat during Long-Term Self-Administration of Nicotine: Disproportionate Increase of the {alpha}6 Subunit
Mol. Pharmacol., March 1, 2004; 65(3): 611 - 622.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
V. P. Grinevich, P. A. Crooks, S. P. Sumithran, A. J. Haubner, J. T. Ayers, and L. P. Dwoskin
N-n-Alkylpyridinium Analogs, a Novel Class of Nicotinic Receptor Antagonists: Selective Inhibition of Nicotine-Evoked [3H]Dopamine Overflow from Superfused Rat Striatal Slices
J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 1011 - 1020.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
N. Champtiaux, C. Gotti, M. Cordero-Erausquin, D. J. David, C. Przybylski, C. Lena, F. Clementi, M. Moretti, F. M. Rossi, N. Le Novere, et al.
Subunit Composition of Functional Nicotinic Receptors in Dopaminergic Neurons Investigated with Knock-Out Mice
J. Neurosci., August 27, 2003; 23(21): 7820 - 7829.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
L. Zhang and R. A. Warren
Muscarinic and Nicotinic Presynaptic Modulation of EPSCs in the Nucleus Accumbens During Postnatal Development
J Neurophysiol, December 1, 2002; 88(6): 3315 - 3330.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Zoli, M. Moretti, A. Zanardi, J. M. McIntosh, F. Clementi, and C. Gotti
Identification of the Nicotinic Receptor Subtypes Expressed on Dopaminergic Terminals in the Rat Striatum
J. Neurosci., October 15, 2002; 22(20): 8785 - 8789.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M.-L. Si and T. J.F. Lee
{alpha}7-Nicotinic Acetylcholine Receptors on Cerebral Perivascular Sympathetic Nerves Mediate Choline-Induced Nitrergic Neurogenic Vasodilation
Circ. Res., July 12, 2002; 91(1): 62 - 69.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. J. Mogg, P. Whiteaker, J. M. McIntosh, M. Marks, A. C. Collins, and S. Wonnacott
Methyllycaconitine Is a Potent Antagonist of alpha -Conotoxin-MII-Sensitive Presynaptic Nicotinic Acetylcholine Receptors in Rat Striatum
J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 197 - 204.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. H. Wilkins Jr., A. Haubner, J. T. Ayers, P. A. Crooks, and L. P. Dwoskin
N-n-Alkylnicotinium Analogs, A Novel Class of Nicotinic Receptor Antagonist: Inhibition of S(-)-Nicotine-Evoked [3H]Dopamine Overflow from Superfused Rat Striatal Slices
J. Pharmacol. Exp. Ther., June 1, 2002; 301(3): 1088 - 1096.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. G. Partridge, S. Apparsundaram, G. A. Gerhardt, J. Ronesi, and D. M. Lovinger
Nicotinic Acetylcholine Receptors Interact with Dopamine in Induction of Striatal Long-Term Depression
J. Neurosci., April 1, 2002; 22(7): 2541 - 2549.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. P. Dwoskin and P. A. Crooks
Competitive Neuronal Nicotinic Receptor Antagonists: A New Direction for Drug Discovery
J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 395 - 402.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M.-L. Si and T. J. F. Lee
Presynaptic alpha 7-Nicotinic Acetylcholine Receptors Mediate Nicotine-Induced Nitric Oxidergic Neurogenic Vasodilation in Porcine Basilar Arteries
J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 122 - 128.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics